The Obesity ETF (SLIM)

Delayed Data
As of Jun 22
 -0.03 / -0.08%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks investment results that correspond generally to the performance- before fees and expenses- of an index which is designed to track the performance of companies globally that are positioned to profit from servicing the obese- including biotechnology- pharmaceutical- health care and medical device companies whose business is focused on obesity and obesity related disease and companies focused on weight loss programs- weight loss supplements- or plus sized apparel. The fund invests at least 80% of its net assets in the stocks that comprise the Solactive Obesity Index. It is non-diversified.

No recent news for The Obesity ETF.


1 month+6.71% 3 years--
3 months+16.17% 5 years--
1 year+37.40% Since inception+21.54%
Data through 06/23/2018

Quote Details

Previous close$37.78
Open day’s range37.49 – 38.25
Net asset value (NAV)37.17 (06/22/2018)
Daily volume2,950
Average volume (3 months)1,861
Data as of 3:12pm ET, 06/22/2018

Peer Comparisonvs. Health ETFs

Performance 5-yr return--+14.29%
Expense Gross exp ratio0.50%1.29%
Risk 5 year sharpe ratio--0.90
Net assets$3.6M$3.0B
Average market cap$7.0B$28.5B
Average P/E27.825.2
Dividend / Share--0.30%


No competitors data available.


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
-- 17.79%
ABMD Abiomed Inc5.36%
DXCM DexCom Inc5.01%
PODD Insulet Corp4.55%
DVA Davita Inc4.40%
-- 4.28%
HLF Herbalife Nutrition Ltd4.16%
WTW Weight Watchers International Inc4.16%
-- 4.12%
-- 4.06%